A Study Of Menstrual Whole Blood, Plasma, And Dried Blood Spots

Overview

About this study

The purpose of this study is to determine the feasibility of performing multi-omic analyses on dried blood spot samples generated from non-invasively collected menstrual blood.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Women of reproductive age (20–45 years old)

  • Periodically menstruating, not pregnant or trying to get pregnant

  • No self reported or diagnosed reproductive health conditions (e.g., endometriosis, PMOS (formerly known as PCOS), uterine fibroids, reproductive cancers)

  • Able to provide informed consent

Exclusion Criteria:

  • Unable to provide informed consent

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 08/03/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Marina Walther-Antonio, Ph.D.

Contact us for the latest status

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions